Fennec Pharmaceuticals Inc. Common Stock FENC
$10.71
+0.75%
at last close
Market Cap$372.76 million
P/E Ratio—
Div Yield—
Volume93.5K
52-Week Range
$5.65$13.25
Analyst Ratings
- Consensus
- Buy — 4 Buy · 0 Hold · 0 Sell (4 analysts)
- Avg. Price Target
- $17.00 (+58.7% upside)
Key Stats
- Today's Range
- $10.57 – $10.86
- 50-Day Range
- $9.40 – $13.25
- 52-Week Range
- $5.65 – $13.25
- Volume
- 93K shs
- Average Volume
- 194K shs
- Market Cap
- $372.76 million
- P/E Ratio
- —
- Dividend Yield
- —
Short Interest
- Short Interest
- 0.07%
- Days to Cover
- 1.00
About Fennec Pharmaceuticals Inc. Common Stock
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
Related Stocks
Compare head-to-head: FENC vs AMGN·FENC vs MRNA·FENC vs HALO·FENC vs IBRX
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.